Novogene Market Cap

Novogene has a market cap or net worth of 6.02 billion as of July 11, 2025. Its market cap has increased by 20.66% in one year.

Market Cap

6.02B

Enterprise Value

4.59B

Revenue

2.14B

Ranking

n/a

PE Ratio

30.57

Stock Price

14.86

Market Cap Chart

Since April 13, 2021, Novogene's market cap has decreased from 10.97B to 6.02B, a decrease of -45.11%. That is a compound annual growth rate of -13.17%.

Market Cap History

Date	Market Cap	% Change
Jul 11, 2025	6.02B	18.88%
Dec 31, 2024	5.06B	-47.88%
Dec 29, 2023	9.71B	-8.02%
Dec 30, 2022	10.56B	-36.10%
Dec 31, 2021	16.53B	50.73%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Hengrui Medicine	379.76B
Shenzhen Mindray Bio-Medical Electronics	267.37B
WuXi AppTec	221.10B
Zhangzhou Pientzehuang Pharmaceutical.,	119.46B
Aier Eye Hospital Group	116.29B
Sichuan Biokin Pharmaceutical	112.78B
Shanghai United Imaging Healthcare	102.91B
Yunnan Baiyao Group Co.,Ltd	100.04B

Market Cap Rankings